期刊文献+

老药新用:氯胺酮的快速抗抑郁作用及其机制研究 被引量:4

New use of old drug: introduction of the antidepressant effects of ketamine and the underlying mechanisms
下载PDF
导出
摘要 氯胺酮是一种非选择性N-甲基-D-天门冬氨酸(NMDA)受体拮抗剂,常作为全身麻醉药用于临床。近年来研究发现,氯胺酮具有快速、有效、持久的抗抑郁作用,该作用可能与抑制性中间神经元、兴奋性神经递激质、AMPA受体及突触后多种信号通路所介导的突触可塑性增强有关。文中简单介绍氯胺酮抗抑郁作用及其机制。 Ketamine, a non-selective N-methyl-D-aspartate (NMDA) receptor antagonist, is widely used as a general anesthetic in clinical practice. Recent studies have shown that ketamine can produce rapid, effective, and long-lasting antidepressant effects, and the strength of synaptic plasticity induced by inhibitory interneurons, excitatory transmitters, AMPA receptors, and postsynaptic signal pathways may be involved in this procedure. The antidepressant effects of ketamine and the underlying mechanisms are concisely introduced in this paper.
作者 杨建军
出处 《医学研究生学报》 CAS 北大核心 2016年第4期337-341,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(81271216 81471105)
关键词 氯胺酮 抑郁症 机制 微清蛋白中间神经元 Ketamine Depression Mechanism Parvalbumin interneurons
  • 相关文献

参考文献33

  • 1刘文学,张广芬,邱丽丽,周志强,杨建军.海马神经元凋亡通路在氯胺酮抗抑郁中的变化[J].医学研究生学报,2015,28(3):236-239. 被引量:5
  • 2Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials[J]. J Clin Psychiatry, 2005, 66(8): 974-981.
  • 3Krishnan V, Nestler EJ. The molecular neurobiology of depression[J]. Nature, 2008, 455(7215): 894-902.
  • 4Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients[J]. Biol Psychiatry, 2000, 47(4): 351-354.
  • 5Zarate CA, Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression[J]. Arch Gen Psychiatry, 2006, 63(8): 856-864.
  • 6Price RB, Nock MK, Charney DS, et al. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression[J]. Biol Psychiatry, 2009, 66(5): 522-526.
  • 7Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department[J]. Int J Neuropsychopharmacol, 2011, 14(8): 1127-1131.
  • 8Zarate CA Jr, Brutsche NE, Ibrahim L, et al. Replication of Ketamine′s Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial[J]. Biol Psychiatry, 2012, 71(11): 939-946.
  • 9Moaddel R, Luckenbaugh DA, Xie Y, et al.D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression[J]. Psychopharmacology (Berl), 2015, 232(2): 399-409.
  • 10Ionescu DF, Luckenbaugh DA, Niciu MJ, et al. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression[J]. BipolarBipolar Disord, 2015, 17(4): 438-443.

二级参考文献25

  • 1Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial[J]. Am J Psychiatry, 2013, 170(10): 1134-1142.
  • 2Zhang GF, Wang N, Shi JY, et al. Inhibition of L-arginine-nitric oxide pathway mediates the antidepressant effects of ketamine on rats in the forced swimming test[J]. Pharmacol Biochem Behav, 2013, 110: 8-12.
  • 3Xu SX, Zhou ZQ, Li XM, et al. The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamine[J]. Behav Brain Res, 2013, 253: 305-309.
  • 4Sequeira A, Mamdani F, Ernst C, et al. Global brain gene expression analysis links glutamatergic and GABA ergic alterations to suicide and major depression[J]. PLoS One, 2009, 4(8): 6585.
  • 5Lee PH, Perlis RH, Jung JY, et al. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder[J]. Transl Psychiatry, 2012, 2: 184.
  • 6Trudeau VL, Kah O, Chang JP, et al. The inhibitory effects of (gamma)-aminobutyric acid (GABA) on growth hormone secretion in the goldfish are modulated by sex steroids[J]. J Exp Biol, 2000, 203(9): 1477-1485.
  • 7De Vry J, Schreiber R, Melon C, et al. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat[J]. Eur Neuropsychopharmacol, 2004, 14(6): 487-495.
  • 8Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists[J]. Science, 2010, 329(5994): 959-964.
  • 9Li N, Liu RJ, Dwyer JM, et al. George Aghajanian, and Ronald S. Duman Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure[J]. Biol Psychiatry, 2011, 69(8): 754-761.
  • 10Dwyer JM, Duman RS. Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-actingantidepressants[J]. Biol Psychiatry, 2013, 73(12): 1189-1198.

共引文献8

同被引文献25

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部